期刊文献+

肺癌患者血清中表皮生长因子受体、HER-2、U1-AsnRNP、p53自身抗体研究进展 被引量:1

Advances of EGFR, HER-2,U1-A snRNP and p53 autoantibodies in serum of lung cancer patients
原文传递
导出
摘要 新近的研究表明,在多种肿瘤包括肺癌患者的血清中,均可检测到针对肿瘤相关抗原的自身抗体。表皮生长因子受体抗体、HER-2抗体、U1-AsnRNP、p53抗体是近年来发现的在肺癌早期诊断中有重要意义的自身抗体,又因为血清中自身抗体检测方便,故上述自身抗体有望成为肺癌早期诊断中重要的分子标志物。 Recent studies have shown that tumor-associated antigen autoantibodies can be detected in the serum of multiple tumor patients, including lung cancer. EGFR ,antibody, HER 2 antibody, U1-A snRNP antibody and p53 antibody are found in the early diagnosis of lung cancer in recent years, and because the detection of autoantibodies is convenient, so these antibodies is expected to become important molecular markers in the early diagnosis of lung cancer.
作者 潘辉 蔡曦光
出处 《国际呼吸杂志》 2011年第18期1415-1418,共4页 International Journal of Respiration
关键词 肺癌 自身抗体 研究进展 Lung cancer Autoantibodies Research advances
  • 相关文献

参考文献25

  • 1Hynes NE, Lane HA. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer, 2005,5:341-354.
  • 2Sharma SV, Settleman J. ErbBs in lung cancer. Exp Cell Res, 2009,315:557-571.
  • 3Ugocsai K, Mandoky L, Tiszlavicz L, et al. Investigation of HER2 overexpression in non small cell lung cancer. Anticancer Res , 2005,25 : 3061-3066.
  • 4李元,许绍发,岳文涛.肺癌患者血清中EGFR和HER-2自身抗体的研究进展[J].中国肺癌杂志,2009,12(10):1115-1118. 被引量:4
  • 5Pupa SM, Menard S, Andreola S, et al. Antibody response against the c-erbB-2 oncoprotein in breast carcinoma patients. Cancer Res, 1993,53 : 5864-5866.
  • 6Chapman CJ, Murray A, McElveen JE,et al. Autoantibodies in lung cancer:possibilities for early detection and subsequent cure. Thorax, 2008,63 : 228-233.
  • 7李元,岳文涛,王玥,张丽娜,顾勐,许绍发.应用多肽芯片研究非小细胞肺癌患者血清中的EGFR自身抗体[J].中国肺癌杂志,2010,13(7):727-730. 被引量:2
  • 8Bei R, Masuelli L, Moriconi E,et al. Immune responses to all ErbB family receptors detectable in serum of cancer patients. Oneogene, 1999,18:1267-1275.
  • 9Fernandez-Madrid F, VandeVord PJ, Yang X, et al. Antinuclear antibodies as potential markers of lung cancer. Clin Cancer Res, 1999,5 : 1393-1400.
  • 10Kubo M, Ihn H, Kuwana M,et al. Anti-US snRNP antibody as a possible serological marker for scleroderma polymyositis overlap. Rheumatology (Oxford) , 2009,41 : 531-534.

二级参考文献55

  • 1何安光.肺癌早期诊断的一些问题[J].中国肿瘤,1994,3(3):7-8. 被引量:3
  • 2Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin, 2007, 57(1): 43-66.
  • 3Cho-Chung YS. Autoantibody biomarkers in the detection of cancer. Biochim Biophys Acta, 2006, 1762(6): 587-591.
  • 4Frank R. Spot-synthesis: an easy technique for the positionally addressable, parallel synthesis on a membrane support. Tetrahedron, 1992, 48: 9217-9232.
  • 5Saleh J, Brunner C, Golzer R, et al. p53 autoantibodies from patients with head and neck cancer recognise common epitopes on the polypeptide chain of p53. Cancer Lett, 2006, 233(1): 48-56.
  • 6Frank R. The SPOT-synthesis technique Synthetic peptide arrays on membrane supports-principles and applications. J Immunol Methods, 2002, 267(1): 13-26.
  • 7Frank R, Overwin H. SPOT-synthesis: epitope analysis with arrays of synthetic peptides prepared on cellulose membranes. Methods Mol Biol, 19961 66: 149-169.
  • 8Kato R, Kunimatsu M, Fujimoto S, et al. Angiotensin Ⅱ inhibitory peptide found in the receptor sequence using peptide array. Biochem Biophys Res Commun, 2004, 315(1): 22-29.
  • 9Guo JP, Petric M, Campbell W, et al. SARS corona virus peptides recognized by antibodies in the sera of convalescent cases. Virology, 2004, 324(2): 251-256.
  • 10Reineke U. Antibody epitope mapping using arrays of synthetic peptides. Methods Mol Biol, 2004, 248: 443-463.

共引文献13

同被引文献10

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部